Sarah Doyle, PhD, and Matthew Campbell, PhD, have spent much of their married life doing research together. In this interview (reposted from 2016), they talk about how their partnership began, what continues to drive them, and surprising turns their work has taken on the path to curing diseases of mind and sight.
For a long time we’ve known that hypertension in midlife increases the risk of Alzheimer’s. Now BrightFocus-funded research is exploring that connection – with some surprising results that are relevant to COVID-19.
Longtime friend and ARVO President Dan Stamer, PhD, tells us about his EyeFind initiative, alternative plans for this year’s annual meeting, how research is a team sport, and why he and other scientists are desperate to get back to the lab.
University of Denver Alzheimer’s researcher Lotta Granholm-Bentley, PhD, DDS, is playing a key role in her community’s medical response to the coronavirus, and working with Colorado seniors to help combat the sense of isolation many are feeling during these difficult times.
This resource discusses medical conditions that can affect driving, safe driving tips and strategies, a self test for drivers, evaluation and discussion of unsafe driving practices, and maintaining independence once a decision is made to stop driving.
Dr. David S. Liao is a board-certified ophthalmologist at the Retina-Vitreous Associates Medical Group in California. He specializes in the medical and surgical treatment of diseases of the retina and vitreous. His main areas of interest include macular degeneration, diabetic retinopathy, disorders of the vitreomacular interface, and retinal detachment repair. View the transcript Print the transcript Listen to the discussion:
The discussion features Sheldon Rowan, PhD of the USDA Human Nutrition Research Center on Aging, Tufts University. Dr. Rowan’s research examines the impact of dietary carbohydrate quality on age-related macular degeneration. View the transcript Print the transcript Listen to the discussion:
BrightFocus Foundation mourns the recent passing of Peter Davies, PhD. A globally-recognized leader in research on Alzheimer’s and related dementia, Dr. Davies served on our Scientific Review Committee for this field for 11 years, including six years as its chair.
In partnership with BrightFocus Foundation, the Medical Technology Enterprise Consortium (MTEC) today announced a request for proposals for research that will enable the advancement of candidate drugs for the treatment of repeated mild traumatic brain injury (mTBI).